Description
Beclate inhaler (Beclomethasone) 200 mcg
Beclate inhaler is a beclometasone dipropionate inhaler, an inhaled corticosteroid used for long-term control of asthma. It is designed to reduce airway inflammation and help maintain better symptom control over time. This medicine is not a rescue inhaler and is not intended for sudden breathing problems.
Active Ingredient and Medicine Class
The verified active ingredient is beclometasone dipropionate, also written as beclomethasone dipropionate in some product information. It belongs to the inhaled corticosteroid class. After inhalation, it acts locally in the lungs to suppress inflammatory processes that contribute to asthma symptoms.
Established Medical Uses
Beclometasone dipropionate inhalers are established for maintenance treatment of asthma and prophylaxis of asthma symptoms. Official prescribing information describes use in patients with asthma who need regular anti-inflammatory controller therapy. It is not indicated for the relief of acute bronchospasm or sudden asthma attacks.
How It Works
Beclometasone dipropionate is a prodrug that is converted in the body to an active metabolite with stronger glucocorticoid activity. In the airways, this reduces inflammation, swelling, and mucus-related irritation, which can help improve breathing control and lower the risk of symptom flare-ups when used regularly as part of asthma management.
Important Safety Information
Beclometasone dipropionate is contraindicated in patients with known hypersensitivity to the active ingredient or any excipients. It is also not suitable as primary treatment for status asthmaticus or other acute episodes requiring urgent measures. Because it is an inhaled corticosteroid, clinically important precautions include local fungal infection in the mouth and throat, possible systemic corticosteroid effects at higher exposure, and possible suppression of growth in children with prolonged use. Caution is also advised in patients whose asthma is worsening despite controller therapy.
Important interactions may occur with medicines that strongly inhibit CYP3A4, which can increase corticosteroid exposure and the risk of systemic effects. As with other inhaled corticosteroids, clinicians may consider the overall corticosteroid burden when beclometasone is used together with other steroid-containing medicines.
Possible Side Effects
Common adverse effects include throat irritation, hoarseness, cough, oral candidiasis, and unpleasant taste. More serious or less common reactions may include paradoxical bronchospasm, allergic reactions, adrenal suppression with excessive corticosteroid exposure, reduced bone mineral density with prolonged high-dose use, cataracts or glaucoma, and growth effects in children. Any new or worsening breathing difficulty after inhalation should be treated as clinically important.
Scientific Evidence
Clinical studies and reviews indexed in PubMed support beclometasone dipropionate as an effective inhaled corticosteroid for persistent asthma, with improvements in lung function and symptom control in appropriate patients. Research also shows that different inhaler devices can deliver clinically useful anti-inflammatory therapy, although the exact performance depends on the device and formulation. These findings support its role as a maintenance controller medicine rather than a reliever.
Medical Information Notice
This summary is provided for educational purposes only and is based on sources available at the time of review. It does not replace the official patient leaflet, the full prescribing information, or individual assessment by a qualified health professional.
Medical Sources
- U.S. Food and Drug Administration / DailyMed. Beclomethasone Dipropionate HFA Inhalation Aerosol, Prescribing Information. View official prescribing information
- electronic Medicines Compendium (emc). Qvar MDI 100 micrograms, Summary of Product Characteristics. View official product information
- electronic Medicines Compendium (emc). Soprobec 100 micrograms per actuation pressurised inhalation solution, Summary of Product Characteristics. View official product information
- Nancy K. Ostrom et al. Randomized trial to assess the efficacy and safety of beclomethasone dipropionate breath-actuated inhaler in patients with asthma. Allergy Asthma Proc., 2018. View scientific article
- R. N. Brogden et al. Beclomethasone dipropionate. A reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis. Drugs, 1984. View scientific article
